Back to search

Article

Reducing Glucocorticoid Burden in Lupus with Omega-3 Fatty Acids: Docosahexaenoic Acid Augments Prednisone Efficacy in Maintaining Cyclophosphamide-Induced Remission of Preclinical Lupus Nephritis

2026-01-08

Abstract excerpt

<h4>Background</h4> Managing lupus nephritis (LN) remains challenging due to relapses after immunosuppressive induction and toxicity from long-term glucocorticoid (GC) maintenance therapy. Dietary omega-3 fatty acids prevent LN onset in preclinical models, but their role in maintaining remission post-induction remains unstudied. <h4>Methods</h4> The silica-accelerated LN (SALN) model using lupus-prone NZBWF1 mic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
df1a3541-327c-573e-a6ea-2749b35bb46a
DOI
10.64898/2026.01.07.698195
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Reducing Glucocorticoid Burden in Lupus with Omega-3 Fatty Acids: Docosahexaenoic Acid Augments Prednisone Efficacy in Maintaining Cyclophosphamide-Induced Remission of Preclinical Lupus NephritisDOI 10.64898/2026.01.07.698195
Select a neighboring publication to make it the new centre.